Clinical Trials

Study Title:
Multiple Part Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma Subjects

For more information about the trial above please contact the study team:

Principal Investigator, Brian Hess, at hessbr@musc.edu.

Study Coordinator, Sarah Britton, at brittosa@musc.edu, or please call +1 843-792-8856.

Trial opened at the following institutions: Medical University of South Carolina